Skip to main content
Equibles

Squarepoint Ops LLC

Position in OCGN — Ocugen, Inc.

CIK 1642575 NEW YORK, NY
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$209,167
-$576,389 QoQ
Shares Held
136,711
-68.5% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 147 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Derivatives in OCGN

reported options exposure · as of Dec 31, 2024
CallValue
$64,158
CallShares
79,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. OCGN ranks #204 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7
290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in OCGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $209,167 136,711
2026-03-31 $785,556 434,009
2025-12-31 $294,829 218,392
2025-09-30 $70,032 42,965
2025-03-31 $21,122 29,919
2024-12-31 $64,158 79,700
2024-12-31 $14,253 17,706
2024-03-31 $235,164 143,393
2022-12-31 $34,970 26,900
2022-09-30 $180,835 101,593
2022-06-30 $52,437 23,100
2021-12-31 $448,648 98,604
2021-09-30 $169,074 23,548
2021-06-30 $954,124 118,820
2021-03-31 $765,042 112,672
2020-12-31 $621,561 339,651
2020-03-31 $9,809 34,909